|
Rekvina Laboratories Ltd.
|
QUARTERLY RESULTS
|
|
|
You can view the
Quaterly Results
for the last 5 years.
|
Market Cap. (Rs.)
|
30.50 Cr.
|
P/BV
|
-22.62
|
Book Value (Rs.)
|
-2.24
|
|
52 Week High/Low (Rs.)
|
50/7
|
FV/ML
|
5/1
|
P/E(X)
|
0.00
|
|
Bookclosure
|
27/09/2024
|
EPS (Rs.)
|
0.00
|
Div Yield (%)
|
0.00
|
|
(Rs. in Crs.)
| Net Sales/Income from operations | 0.67 | 0.72 | 0.35 | 0.20 | 0.00 |
| Total Income From Operations | 0.67 | 0.72 | 0.35 | 0.20 | 0.00 |
| Purchase of Traded Goods | 0.70 | 0.67 | 0.33 | 0.18 | 0.00 |
| Increase/Decrease in Stocks | -0.04 | 0.00 | 0.00 | 0.00 | 0.00 |
| Employees Cost | 0.04 | 0.06 | 0.10 | 0.04 | 0.03 |
| Other Expenses | 0.09 | 0.05 | 0.04 | 0.02 | 0.01 |
| Total Expenses | 0.79 | 0.78 | 0.47 | 0.23 | 0.04 |
| | | | | | |
| P/L Before Other Inc. , Int., Excpt. Items & Tax | -0.12 | -0.06 | -0.12 | -0.03 | -0.04 |
| P/L Before Interest, Excpt. Items & Tax | -0.12 | -0.06 | -0.12 | -0.03 | -0.04 |
| P/L Before Exceptional Items & Tax | -0.12 | -0.06 | -0.12 | -0.03 | -0.04 |
| P/L Before Tax | -0.12 | -0.06 | -0.12 | -0.03 | -0.04 |
| P/L After Tax from Ordinary Activities | -0.12 | -0.06 | -0.12 | -0.03 | -0.04 |
| Net Profit/Loss For the Period | -0.12 | -0.06 | -0.12 | -0.03 | -0.04 |
| | | | | | |
| Equity Share Capital | 3.01 | 3.01 | 3.01 | 3.01 | 3.01 |
| EPS Before Extra Ordinary * | | | | | |
| Basic EPS (Rs.) | -0.20 | -0.10 | -0.21 | -0.06 | -0.05 |
| Diluted EPS (Rs.) | -0.20 | -0.10 | -0.21 | -0.06 | (0.07) |
| EPS After Extra Ordinary * | | | | | |
| Basic EPS (Rs.) | -0.20 | -0.10 | -0.21 | -0.06 | -0.05 |
| Diluted EPS (Rs.) | -0.20 | -0.10 | -0.21 | -0.06 | 0.00 |
| | | | | | |
| PBITOE Margin (%) | -18.02 | -8.36 | -35.85 | -17.78 | N.A |
| PBTE Margin (%) | -18.02 | -8.36 | -35.85 | -17.78 | N.A |
| PBT Margin (%) | -18.02 | -8.36 | -35.85 | -17.78 | N.A |
| PAT Margin (%) | -18.02 | -8.36 | -35.85 | -17.78 | N.A |
